Fixed-dose drug combinations
Assessment of utilization pattern of fixed dose drug combinations in primary, secondary and tertiary healthcare centers in Nepal: a cross-sectional study
10
Assessment of the availability and rationality of unregistered fixed dose drug combinations in Nepal: a multicenter cross-sectional study
13
A STUDY OF PREVAILING SCENARIO OF FIXED-DOSE DRUG COMBINATIONS (FDCs) AVAILABLE IN INDIAN MARKET
9
Assessment of rational use of fixed dose combinations in hypertension in a tertiary care teaching hospital in north India
5
FORMULATION AND EVALUATION OF FIXED DOSE COMBINATIONS OF ANTI HYPERTENSIVE DRUGSAlladi Saritha,Vunnam Manoj*DOWNLOAD/VIEW
5
Development and Validation of a Novel Isocratic RP HPLC Method For Simultaneous Determination of Atenolol and Aspirin in Fixed dose combinations
9
Do fixed dose combinations play an important role in the management of coexistent type two diabetes mellitus and hypertension?
10
Development and validation of RP HPLC method for simultaneous determination of metoprolol and aspirin in fixed dose combinations
5
Comparitive Stability Studies on Rifampicin in Fixed Dose Combinations Between Blister and Strip Packaged Marketed Products
109
Enhancement in Stabilityand In-Vivo Bioavailability of Rifampicin Alone and in Combination with Isoniazidusing Ascorbic Acid.
106
An evaluation of fixed dose combinations and it’s practices at medicine department of tertiary care hospital, Nepal
6
Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated <em>falciparum</em> malaria in pregnancy: a randomized open label study
10
ASSESSMENT OF RATIONAL USE OF FIXED DOSE COMBINATION IN COMMUNITY PHARMACIES OF RESOURCE LIMITED SETTINGS OF ANDHRA PRADESH
6
ASSESSMENT OF KNOWLEDGE, ATTITUDE AND PRACTICE OF PRESCRIBING FIXED DOSE COMBINATIONS AMONG POSTGRADUATE MEDICAL STUDENTS – A CROSS SECTIONAL SURVEY
7
<p>Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study</p>
13
Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
19
COMPARATIVE STUDY ON SAFETY AND EFFICACY OF CHLORZOXAZONE VERSUS THIOCOLCHICOSIDE IN COMBINATION WITH PARACETAMOL AND ACECLOFENAC IN PATIENTS WITH ACUTE LOW BACKACHE ASSOCIATED WITH MUSCLE SPASM
7
Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs
9
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
16
The Implications of Fixed Dose Combination (FDC) Compared to Single Pill Combinations (SPC): Based on Patients’ View
10